CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-748 Cr | ₹-591 Cr | ₹-403 Cr | ₹-293 Cr | ₹-205 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of CIPLA ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹-748 Cr |
| Mar2025 | ₹-591 Cr |
| Mar2024 | ₹-403 Cr |
| Mar2023 | ₹-293 Cr |
| Mar2022 | ₹-205 Cr |
How is Deferred Tax Assets / Liabilities of CIPLA Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-748 Cr | Negative | |
| Mar2025 | ₹-591 Cr | Negative | |
| Mar2024 | ₹-403 Cr | Negative | |
| Mar2023 | ₹-293 Cr | Negative | |
| Mar2022 | ₹-205 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹117,813.6 Cr | 0.3% | 6.1% | -3.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,989.0 Cr | 1.7% | 6.4% | 12.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,471.0 Cr | 3% | 2.8% | 0.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,290.0 Cr | 2.3% | 9.1% | 44.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,730.0 Cr | -0.1% | 8.9% | 1.9% | Stock Analytics | |
| MANKIND PHARMA | ₹104,535.0 Cr | 1.8% | 6.7% | 8% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 0.3% |
6.1% |
-3.7% |
| SENSEX | 0.9% |
4.2% |
-6% |
You may also like the below Video Courses